SANA

SANA BIOTECHNOLOGY, INC.

SANA · CIK 1770121 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$267M
20212024
Operating CF−$223M
20212024
Free Cash Flow−$257M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.2B$0.3B$0.3B$0.2B
SG&A Expense————
Operating Income$-0.3B$-0.3B$-0.3B$-0.4B
Net Income$-0.3B$-0.3B$-0.3B$-0.4B
EPS (Basic)$-1.16$-1.46$-1.43—
EPS (Diluted)$-1.16$-1.46$-1.43—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.5B$0.6B$0.8B$1.1B
Current Assets$0.2B$0.2B$0.4B$0.6B
Cash & Equivalents$0.1B$0.1B$0.2B$0.3B
Total Liabilities$0.3B$0.3B$0.3B$0.4B
Current Liabilities$0.0B$0.1B$0.1B$0.1B
Stockholders' Equity$0.3B$0.3B$0.5B$0.7B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.2B$-0.3B$-0.3B$-0.3B
Investing Cash Flow$0.0B$0.2B$0.2B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.2B$0.0B$0.0B$0.6B
← Companies